ADMA Biologics, Inc. Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

6 Months Ended

Jun. 30, 2021

6.	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities at June 30, 2021 and December 31, 2020 are as follows:

	June 30, 2021		December 31, 2020
Accrued rebates	$	3,721,888	$	2,604,245
Accrued distribution fees		1,928,901		828,120
Accrued payroll		691,483		734,972
Accrued testing		1,673,120		779,660
Accrued incentives		1,539,491		3,210,884
Accrued severance		789,534		-
Other		1,145,822		207,262
Total accrued expenses and other current liabilities	$	11,490,239	$	8,365,143